Interstitial lung diseases;Pneumopatie interstiziali

Recenti Progressi in Medicina

Volumn 94, Issue 5, 2003, Pages 227-237

  Mazzoccoli, Gianluigi ^a   Carughi, Stefano ^a   De Cata, Angelo ^a   Giuliani, Antonio ^a   Masciale, Nunzia ^a   La Viola, Marco ^a   Puzzolante, Felice ^a   Balzanelli, Mario ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SS Annunziata Hospital   (Italy)

Author keywords

Classification; Clinics; Interstitial pneumonia; Treatment

Indexed keywords

AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

CLINICAL FEATURE; DEATH; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DYSPNEA; FUNCTIONAL ANATOMY; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLITIS; LUNG FIBROSIS; PATHOGENESIS; RESPIRATORY FAILURE; REVIEW; THORAX RADIOGRAPHY; ADULT; BIOPSY; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSCOPY; CLASSIFICATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; GLOMERULONEPHRITIS; LUNG; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MIDDLE AGED; PATHOLOGY; PLASMAPHERESIS; RISK FACTOR; SARCOIDOSIS; SCINTISCANNING;

ADRENAL CORTEX HORMONES; ADULT; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BIOPSY; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSCOPY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; MIDDLE AGED; PLASMAPHERESIS; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SARCOIDOSIS, PULMONARY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037709937     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Cherniack RM, Colby TV, Flint A, et al. Correlation of structure and function in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 1180-8.
2. Katzenstein ALA, Fiorelli RF. Non-specific interstitial pneumonia/fibrosis: histologic patterns and clinical significance. Am J Surg Pathol 1994; 18: 136-47.
3. Agusti C, Xaubet A, Roca J, et al. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up. Thorax 1992; 47: 1035-40.
4. Wells AU, Cullinan P, Hansell DM, et al. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994; 149: 1583-90.
5. Hanson D, Winterbauer RH, Kirtland SH, et al. Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. Chest 1995; 108: 305-10.
6. Carrington CB, Gaensler EA, Coutu RE, et al: Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801-9.
7. Guerry Force ML, Muller NL, Wright JL, et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease. Am Rev Respir Dis 1987; 135: 705-12.
8. Colby TV. Bronchiolitis. Pathologic considerations. Am J Clin Pathol 1998; 109: 101-6.
9. Paradis I. Bronchiolitis obliterans: pathogenesis, prevention and management. Am J Med Sci 1998; 315: 161-72.
10. Epler GR. Bronchiolitis obliterans organizing pneumonia. Arch Intern Med 2001; 161:158-64.
11. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989; 64: 1373-80.
12. Primack SL, Hartman TE, Ikezoe J, et al. Acute interstitial pneumonia: radiographic and CT findings in nine patients. Radiology 1993; 188: 817-20.
13. Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis: ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol 1991; 138: 1257-65.
14. Bensadoun ES, Burke AK, Hogg JC, et al. Proteoglycan deposition in pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154: 1819-28.
15. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathological subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199-203.
16. Lipworth B, Woodcock A, Addis B, et al. Late relapse of desquamative interstitial pneumomia. Am Rev Respir Dis 1987; 136: 1253-5.
17. Marshall RP, Puddicombe A, Cookson WOC, et al. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000; 55: 143-146.
18. Sattler F, Nichols L, Hirano L, et al. Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1997; 156: 912-7.
19. Watters LC, Schwarz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987; 135: 696-704.
20. Akira M, Yamamoto S, Hara H, et al. Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 1997; 52: 333-7.
21. Hartman TE, Primack SL, Kang EY, et al. Disease progression in usual interstitial pneumomia compared with desquamative interstitial pneumonia: assessment with serial CT. Chest 1996; 110: 378-82.
22. Park JS, Lee KS, Kim JS, et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: 645-8.
23. Akira M, Sakatani M, Ueda E. Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. Radiology 1993; 189: 687-91.
24. Hunninghake GW, Schwartz D, King T, et al. Open lung biopsy in IPF. Am J Respir Crit Care Med 1998; 157 (suppl 2): A277.
25. Mason RJ, Schwartz MI, Hunninghake GW, et al. Pharmacological therapy for idiopathic pulmonary fibrosis: past, present, and future. Am J Respir Crit Care Med 1999; 160: 1771-7.
26. Idiopathic pulmonary fibrosis: diagnosis and treatment: international consensus statement. Am J Respir Crit Care Med 2000; 161: 646-64.
27. Johnson MA, Kwan S, Snell NJC, et al. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989; 44: 280-8.
28. Iyer SN, Gurujeyalakshmi G, Giri SN: Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J Pharmacol Exp Ther 1999; 289: 211-8.
29. Bani D: Relaxin: a pleiotropic hormone. Gen Pharmacol 1997; 28: 13-22.
30. Unemori EN, Pickford LB, Salles AL, et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 1996; 98: 2739-45.
31. Seibold JR, Korn JH, Simms R, et al. Recombinant human relaxin in the treatment of scleroderma: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 132: 871-9.
32. Teder P, Noble PW: A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis. Am J Respir Cell Mol Biol 2000; 23: 7-10.
33. Marshall RP, McAnulty RJ, Laurent GJ: Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 2000; 161: 1999-2004.
34. Meyers BF, Lynch J, Trulock EP, et al. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg 2000; 120: 99-107.
35. Raghu G, Depaso WJ, Cain K, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991; 144: 291-296.
36. Huang M, Sharma S, Zhu LX, et al. IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis. J Clin Invest 2002; 109: 931-7.
37. Baughman RP, Lower EE: Use of intermittent, intravenous cyclophosphamide for idiopathic pulmonary fibrosis. Chest 1992; 102: 1090-4.
38. Hunninghake GW, Kalica AR: Approaches to the treatment of pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 915-8.
39. Johnson MA, Kwan S, Snell NJC, et al. Randomized controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989; 44: 280-8.
40. Douglas WW, Ryu JH, Bjoraker JA, et al. Colchicine versus prednisone as treatment of usual interstitial pneumonia. Mayo Clin Proc 1997; 72: 201-9.